265 related articles for article (PubMed ID: 34706771)
1. Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis.
Doumen M; De Cock D; Pazmino S; Bertrand D; Joly J; Westhovens R; Verschueren P
Arthritis Res Ther; 2021 Oct; 23(1):269. PubMed ID: 34706771
[TBL] [Abstract][Full Text] [Related]
2. Psychosocial Burden Predicts Sustained Remission in Early Rheumatoid Arthritis: Unraveling the Complex Interplay of Well-Being and Disease Activity.
Doumen M; De Cock D; Pazmino S; Bertrand D; Joly J; Westhovens R; Verschueren P
Arthritis Care Res (Hoboken); 2023 Apr; 75(4):758-767. PubMed ID: 34931480
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach.
Kuusalo L; Puolakka K; Kautiainen H; Karjalainen A; Malmi T; Yli-Kerttula T; Leirisalo-Repo M; Rantalaiho V;
Rheumatol Int; 2017 May; 37(5):825-830. PubMed ID: 28289873
[TBL] [Abstract][Full Text] [Related]
4. Are illness perception and coping style associated with the delay between symptom onset and the first general practitioner consultation in early rheumatoid arthritis management? An exploratory study within the CareRA trial.
Van der Elst K; De Cock D; Vecoven E; Arat S; Meyfroidt S; Joly J; Moons P; Verschueren P; Westhovens R; CareRA Study Group
Scand J Rheumatol; 2016; 45(3):171-8. PubMed ID: 26399601
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
[TBL] [Abstract][Full Text] [Related]
6. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
7. Patient-Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target.
Van der Elst K; Verschueren P; Stouten V; Pazmino S; De Groef A; De Cock D; Joly J; Moons P; Westhovens R
Arthritis Care Res (Hoboken); 2019 Dec; 71(12):1566-1575. PubMed ID: 30951267
[TBL] [Abstract][Full Text] [Related]
8. Randomised controlled trial of tumour necrosis factor inhibitors against combination intensive therapy with conventional disease-modifying antirheumatic drugs in established rheumatoid arthritis: the TACIT trial and associated systematic reviews.
Scott DL; Ibrahim F; Farewell V; O'Keeffe AG; Ma M; Walker D; Heslin M; Patel A; Kingsley G
Health Technol Assess; 2014 Oct; 18(66):i-xxiv, 1-164. PubMed ID: 25351370
[TBL] [Abstract][Full Text] [Related]
9. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.
Furst DE; Kavanaugh A; Florentinus S; Kupper H; Karunaratne M; Birbara CA
Rheumatology (Oxford); 2015 Dec; 54(12):2188-97. PubMed ID: 26199453
[TBL] [Abstract][Full Text] [Related]
10. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
[TBL] [Abstract][Full Text] [Related]
11. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.
Fanouriakis A; Papalopoulos I; Gergianaki I; Spyrou G; Erden A; Rapsomaniki P; Terizaki M; Avgoustidis N; Repa A; Kougkas N; Bertsias G; Boumpas DT; Sidiropoulos PI
Clin Exp Rheumatol; 2018; 36(5):806-813. PubMed ID: 29533750
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data.
Duong SQ; Crowson CS; Athreya A; Atkinson EJ; Davis JM; Warrington KJ; Matteson EL; Weinshilboum R; Wang L; Myasoedova E
Arthritis Res Ther; 2022 Jul; 24(1):162. PubMed ID: 35778714
[TBL] [Abstract][Full Text] [Related]
13. Do it fast! Early access to specialized care improved long-term outcomes in rheumatoid arthritis: data from the REAL multicenter observational study.
Albuquerque CP; Reis APMG; Vargas Santos AB; Bértolo MB; Júnior PL; Neubarth Giorgi RD; Radominski SC; Guimarães MFBR; Bonfiglioli KR; L Cunha Sauma MF; Pereira IA; Brenol CV; Henrique Mota LM; Santos-Neto L; Castelar Pinheiro GR
Adv Rheumatol; 2023 Apr; 63(1):17. PubMed ID: 37095556
[TBL] [Abstract][Full Text] [Related]
14. Gain in quality-adjusted life-years in patients with rheumatoid arthritis during 1 year of biological therapy: a prospective study in clinical practice.
Linde L; Sørensen J; Østergaard M; Hetland ML
J Rheumatol; 2013 Sep; 40(9):1479-86. PubMed ID: 23818719
[TBL] [Abstract][Full Text] [Related]
15. Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
Avila-Ribeiro P; Brault Y; Dougados M; Gossec L
Clin Exp Rheumatol; 2017; 35(5):786-790. PubMed ID: 28339355
[TBL] [Abstract][Full Text] [Related]
16. Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis.
Revicki D; Ganguli A; Kimel M; Roy S; Chen N; Safikhani S; Cifaldi M
Value Health; 2015 Dec; 18(8):1008-15. PubMed ID: 26686785
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response.
Doumen M; Pazmino S; Bertrand D; De Cock D; Joly J; Westhovens R; Verschueren P
Ann Rheum Dis; 2022 Oct; 81(10):1385-1391. PubMed ID: 35725296
[TBL] [Abstract][Full Text] [Related]
18. Remission vs low disease activity: function, quality of life and structural outcomes in the Early Rheumatoid Arthritis Study and Network.
Nikiphorou E; Norton SJ; Carpenter L; Walsh DA; Creamer P; Dixey J; Young A; Kiely PDW;
Rheumatology (Oxford); 2020 Jun; 59(6):1272-1280. PubMed ID: 31580448
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials.
Combe B; Allanore Y; Alten R; Caporali R; Durez P; Iannone F; Nurmohamed MT; Toumi M; Lee SJ; Kwon TS; Noh J; Park G; Yoo DH
Arthritis Res Ther; 2021 Apr; 23(1):119. PubMed ID: 33863352
[TBL] [Abstract][Full Text] [Related]
20. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
